Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antibody for specific binding with highly-pathogenic avian influenza virus

An avian influenza virus, highly pathogenic technology, applied in the direction of antibodies, antiviral agents, antiviral immunoglobulins, etc.

Active Publication Date: 2014-01-01
XIAMEN UNIV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method also has certain limitations. After all, there are certain differences in the known antibody sequences, especially the CDR region sequence.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody for specific binding with highly-pathogenic avian influenza virus
  • Antibody for specific binding with highly-pathogenic avian influenza virus
  • Antibody for specific binding with highly-pathogenic avian influenza virus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1: Preparation of HAO fusion protein used as antigen

[0037] Construction of expression recombinant vector and transfection expression

[0038] The HA0 gene of influenza virus H5N1 subtype A / Ck / HK / YU777 / 02 was retrieved by our laboratory, and primers were designed, using the HA0 gene of A / Ck / HK / YU777 / 02 as a template, and the signal peptide and its preceding base were removed The base sequence (48bp), plus the signal peptide of TPA (105bp); remove the transmembrane region (108bp) at the tail of HA0, plus a sequence (135bp) with 6 His (the bacteriophage T4 fibritin foldon trimerization sequence), the construction see Figure 6 . It was inserted into the expression vector PTT5, and then the transfection density was 8×10 6 cells / ml CHO-S cells for expression.

[0039] Table 1. HA0 gene cloning primers

[0040]

[0041] HA0 purification

[0042] Because a HIS tag was added to the end of the HAO gene when the recombinant vector was constructed, the HIS tag ...

Embodiment 2

[0045] Example 2: CDR replacement experiment of humanized antibody 37 hAb

[0046] In the previous research, we have obtained the broad-spectrum neutralizing antibody 13D4 of highly pathogenic avian influenza virus (produced by the hybridoma cell line with the deposit number CCTCC-C200721), and then humanized it to obtain human Antibody 37 hAb, whose heavy chain variable region amino acid sequence is SEQ ID NO: 13, and light chain variable region amino acid sequence is SEQ ID NO: 14, still retains the broad-spectrum neutralizing activity of 13D4 mouse monoclonal antibody, and in animals Experiments have shown good therapeutic effects. Because in the process of antigen-antibody binding, the site that directly interacts with the antigen is mainly the CDR region. Many studies have shown that not all of the six CDRs of the heavy chain and light chain are key regions for antigen-antibody binding. Several CDR regions are key regions, so the CDR replacement method can be used to pre...

Embodiment 3

[0066] Example 3: Construction of humanized antibody 37 phage ScFv

[0067] After obtaining the sequences of the 37hAb heavy chain variable region and light chain variable region, primers were designed and constructed on the phage vector pCANTAB 5E to form a phage-ScFv recombinant vector. Wherein ScFv is constructed into a kind of VH-(G 4 S) 3 - In the VL form, there is a connecting peptide consisting of 15 amino acids between the heavy chain variable region sequence and the light chain variable region sequence, and the existence of the connecting peptide will not affect the correct folding of the ScFv.

[0068] Construction of 37 phage recombinant vectors

[0069] After obtaining the sequences of the variable region of the heavy chain and the variable region of the light chain of 37hAb, the upstream and downstream primers 37VHF, 37VHR and 37VKF, 37VKR at both ends were designed respectively for the sequence of the variable region of the heavy chain and the sequence of the v...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a broad spectrum humanized monoclonal antibody, which can specifically bind with highly-pathogenic avian influenza virus H5N1 and is obtained through following one or more mutation of an antibody 37 hAb, which is obtained by humanization of a monoclonal antibody 13D4, which is produced by a hybridoma cell strain with a preservation number of CCTCC-C200721; wherein the mutations is as follows: the 100th F position of the heavy chain CDR3 can mutate into L, S, Y, N, or T, the 102nd position V can mutate into E, Q, K, D, or T; the 51st position I of the heavy chain CDR2 can mutate into M, V, or S, the 54th position S can mutate into T, A, P, or V, the 57th position I can mutate into S, W, or D, the 59th position Y can mutate into A, F, C, or E; and applications of these antibodies on preventing and curing of highly-pathogenic avian influenza virus diseases.

Description

technical field [0001] The invention relates to a broad-spectrum humanized monoclonal antibody against highly pathogenic avian influenza virus H5N1, which can be used for the prevention and treatment of highly pathogenic avian influenza. Background technique [0002] Native intact immunoglobulins are usually Y-shaped, with an antigen-binding site at the end of each upper arm of the Y-shaped antibody molecule. Specifically, a target binding site consists of a heavy chain variable region (VH) combined with a light chain variable region (VL). On the target binding site of the antibody, the hypermutation region above the variable region of the heavy chain and the variable region of the light chain, that is, the CDR region, plays a key role in binding. Each variable region of the heavy chain and the variable region of the light chain are respectively Contains 3 CDR regions, so a target binding site of an antibody has a total of 6 CDR regions. [0003] The division of the heavy ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/10A61K39/42A61P31/16
Inventor 罗文新霍永庭李善伟崔传佳陈毅歆夏宁邵
Owner XIAMEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com